-
Mayo Clinic Laboratories and KYAN Technologies enter a collaboration to expand patients’ access to cancer testing
Share this:
ROCHESTER, Minn. and SINGAPORE — Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and KYAN Technologies, a leader in functional precision medicine for oncology, today announced a collaboration to validate and provide the KYAN test, Optim.AI™, across the United States. This collaboration aims to support clinicians with additional testing insights for cancer treatment.
Learn more here.
